Progress + promise — Inside Henry Ford Health System's precision medicine journey


This webinar is on-demand and can be viewed at your convenience.

Genomic testing, once only aspirational in the medical community, is now available to clinicians across a spectrum of practices. From oncology and cardiovascular diseases to surgical and infectious diseases, clinical genomic testing touches patients in dozens of categories. In 2000, whole-genome sequencing was ground-breaking. More than 20 years later, it is now considered medically necessary.

During a featured session as part of Becker's 12th Annual CEO + CFO roundtable, two leaders discussed Detroit-based Henry Ford Health system's precision medicine journey.

Watch now to learn more about:
  • Targeted therapies and clinical trial enrollments.
  • Generating a comprehensive clinically actionable genomic profile.
  • Improving the ease of onboarding.
  • How to get results quickly with in-house testing.

Presenters:

Damon Hostin - Sarah Simon

Damon Hostin

Lead, Market Access, Health Systems, Illumina

Tom Mikkelsen - Sarah Simon

Tom Mikkelsen, MD, FRCP, DABNP

Medical Director, Jeffries Precision Medicine Center and Professor of Neurology, Wayne State University

Mike K - Sarah Simon

Mike Kreitzinger

Lead Health System Strategy, Illumina

By registering, you agree to Becker's Healthcare terms of service and privacy policy.